Cite

HARVARD Citation

    Dimachkie, M. et al. (2022). Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease. Neurology. pp. e536-e548. [Online]. 
  
Back to record